JSB Market Research: Myasthenia Gravis - Pipeline Review, H2 2014
This report provides comprehensive information on the therapeutic development for Myasthenia Gravis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. See Full Report @ http://bit.ly/1BXnzhj
This report provides comprehensive information on the therapeutic development for Myasthenia Gravis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
See Full Report @ http://bit.ly/1BXnzhj
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Jun 20, 2013: Alnylam Scientists Present Preclinical Data With ALN-CC5 For Treatment Of<br />
Complement-mediated Diseases 89<br />
Mar 21, 2013: Cytokinetics Announces Presentation Of Phase IIA Clinical Trial Data Of<br />
Tirasemtiv In Patients With <strong>Myasthenia</strong> <strong>Gravis</strong> 90<br />
Mar 13, 2013: Cytokinetics Announces Presentation Of Phase IIa Trial Data On Tirasemtiv At<br />
65th AAN Annual Meeting 91<br />
Appendix 92<br />
Methodology 92<br />
Coverage 92<br />
Secondary <strong>Research</strong> 92<br />
Primary <strong>Research</strong> 92<br />
Expert Panel Validation 92<br />
Contact Us 93<br />
Disclaimer 93<br />
List Of Tables<br />
Number of Products under Development for <strong>Myasthenia</strong> <strong>Gravis</strong>, <strong>H2</strong> <strong>2014</strong> 9<br />
Number of Products under Development for <strong>Myasthenia</strong> <strong>Gravis</strong> - Comparative Analysis, <strong>H2</strong><br />
<strong>2014</strong> 10<br />
Number of Products under Development by Companies, <strong>H2</strong> <strong>2014</strong> 12<br />
Number of Products under Investigation by Universities/Institutes, <strong>H2</strong> <strong>2014</strong> 13<br />
Comparative Analysis by Late Stage Development, <strong>H2</strong> <strong>2014</strong> 14<br />
Comparative Analysis by Clinical Stage Development, <strong>H2</strong> <strong>2014</strong> 15<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
Change language